11 results · 8ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MiniCap Extended Life PD Transfer Set

FDA Enforcement
Class II ·Terminated·Baxter Healthcare Corporation·January 13, 2021

MONARCH Bronchoscope. Model Number: MBR-000211-B

FDA Enforcement
Class II ·Ongoing·Auris Health, Inc·November 26, 2025

American Contract Systems Biopsy Drape Pack convenience kit

FDA Enforcement
Class II ·Ongoing·American Contract Systems, Inc.·August 14, 2024

American Contract Systems Laparoscopy Litho Std Pack convenience kit and American Contract Systems Lap Chole convenience kit

FDA Enforcement
Class II ·Ongoing·American Contract Systems, Inc.·August 14, 2024

SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706

FDA Enforcement
Class II ·Ongoing·Beckman Coulter Inc.·November 12, 2025

BD Texium: 3 mL, REF: MY8003-0006; 5 mL, REF: MY8005-0006; 10 mL, REF: MY8010-0006; 20 mL, REF: MY8020-0006; 30 mL, REF: MY8030-0006; 60 mL, REF: MY8060-0006

FDA Enforcement
Class II ·Ongoing·BD SWITZERLAND SARL·June 18, 2025

American Contract Systems Special Procedure Pack convenience kit

FDA Enforcement
Class II ·Ongoing·American Contract Systems, Inc.·August 14, 2024

American Contract Systems Gyn Laparoscopy convenience kit

FDA Enforcement
Class II ·Ongoing·American Contract Systems, Inc.·August 14, 2024

BIOFIRE Blood Culture Identification 2 (BCID2) Panel, REF: RFIT-ASY-0147, for FILMARRAY Systems, when used in conjunction with Culture Media Bottles: BACT/ALERT FA PLUS, REF: 410851, and BACT/ALERT PF PLUS, REF: 410853

FDA Enforcement
Class II ·Ongoing·BioFire Diagnostics, LLC·August 7, 2024

BD Texium Needle-Free Syringe: 3 mL, REF: MY8003; 5 mL, REF: MY8005; 10 mL, REF: MY8010; 20 mL, REF: MY8020; 30 mL, REF: MY8030; 60 mL, REF: MY8060

FDA Enforcement
Class II ·Ongoing·BD SWITZERLAND SARL·June 18, 2025

St. Jude Medical CONFIRM Rx Insertable Cardiac Monitor, Sterile EO, Model #: DM3500 The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 11, 2018